Kurt Karst: FDA does a poor job of getting info to the public
The Food and Drug Administration has a special, streamlined process for approving generics. Trouble is, the public announcements of FDA's decisions often get bo...
The Food and Drug Administration has a special, streamlined process for approving generics. Trouble is, the public announcements of FDA's decisions often get bottled up. Attorney Kurt Karst, a director at Hyman, Phelps and McNamara, tells Federal Drive with Tom Temin that irritates and frustrates everyone, including drug companies, investors, federal judges and the public.